Study of LW402 in Moderate-to-Severe Atopic Dermatitis

NCT07186387 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis (AD)

Interventions

DRUG: LW402
DRUG: LW402 placebo

Sponsor

Shanghai Longwood Biopharmaceuticals Co., Ltd.